COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,871 Articles (22,568 medRxiv, 8,303 bioRxiv)

Most recent first Previous |  Page 1930: Articles 19291-19300  | Next

Using Administrative Data to Incorporate Age and Sex-Dependent Resource Use for COVID-19 Acute Care Resource Use Simulations in Ontario, Canada
Mac, S., Ximenes, R., Barrett, K., Khan, Y. A., Pechlivanoglou, P., Rios, J. D., Naimark, D. M., Sander, B.
10.1101/2020.12.16.20248166 — Posted: 2020-12-18
Optimality in COVID-19 vaccination strategies determined by heterogeneity in human-human interaction networks
Goldenbogen, B., Adler, S. O., Bodeit, O., Wodke, J., Escalera-Fanjul, X., Korman, A., Krantz, M., Bonn, L., Moran Torres, R. U., Haffner, J. E., Karnetzki, M., Maintz, I., Mallis, L., Prawitz, H., Segelitz, P. S., Seeger, M., Linding, R., Klipp, E.
10.1101/2020.12.16.20248301 — Posted: 2020-12-18
Renal Involvement in Patients with COVID-19 Pneumonia and Outcomes After Stem Cell Nebulization.
Torres Zambrano, G. M., Villegas Valverde, C. A., Bencomo Hernandez, A., Hadi, L. A., Rivero, R. A., Ventura Carmenate, Y.
10.1101/2020.12.16.20236877 — Posted: 2020-12-18
Effect of COVID-19 on Critical ICU Capacity in US Acute Care Hospitals
Tsai, T. C., Jacobson, B. H., Jha, A. K.
10.1101/2020.12.16.20248366 — Posted: 2020-12-18
Internal medicine clerkship amidst COVID-19 pandemic: clinical learning experience of undergraduate medical students at Makerere University, Uganda: a cross-sectional study
Bongomin, F., Olum, R., Nakiyingi, L., Rejani, L., Ssinabulya, I., Sekaggya-Wiltshire, C., Ocama, P., Byakika-Kibwika, P.
10.1101/2020.12.16.20248110 — Posted: 2020-12-18
Voxel-level forecast system for lesion development in patients with COVID-19
Jin, C., Duan, Y., Cao, Y., Yu, J., Xu, Z., Chen, W., Han, X., Liu, J., Zhou, J., Shi, H., Feng, J.
10.1101/2020.12.17.20248377 — Posted: 2020-12-18
Covid-19 Vaccine Efficacy: Accuracy, Uncertainty and Projection of Cases
Fu, W., Li, J., Scheet, P.
10.1101/2020.12.16.20248359 — Posted: 2020-12-18
Interim evaluation of Google AI forecasting for COVID-19 compared with statistical forecasting by human intelligence in the first week
Kurita, J., Sugawara, T., Ohkusa, Y.
10.1101/2020.12.16.20248358 — Posted: 2020-12-18
SIREN protocol: Impact of detectable anti-SARS-CoV-2 on the subsequent incidence of COVID-19 in 100,000 healthcare workers: do antibody positive healthcare workers have less reinfection than antibody negative healthcare workers?
Wallace, S., Hall, V., Charlett, A., Kirwan, P. D., Cole, M. J., Shrotri, M., Rokadiya, S., Oguti, B., Vusirikala, A., Zambon, M., Brooks, T., Ramsay, M., Brown, C. S., Chand, M. A., Hopkins, S.
10.1101/2020.12.15.20247981 — Posted: 2020-12-18 Discussion: Onsite
Sub-national forecasts of COVID-19 vaccine acceptance across the UK: a large-scale cross-sectional spatial modelling study
de Figueiredo, A.
10.1101/2020.12.17.20248382 — Posted: 2020-12-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).